Disclosure Of Interests In Other Entities [Text Block]

ERYTECH Pharma S.A. - Filing #2813524

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	Principes de consolidation	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	42 634 EUR	—	—	—	—	—	—	40 048 EUR	—	—	—	—	—	—	—	—	—	49 632 EUR	—	—	—	—
Non-current assets	3 177 EUR	—	—	—	—	—	—	26 720 EUR	—	—	—	—	—	—	—	—	—	30 770 EUR	—	—	—	—
Current liabilities	11 678 EUR	—	—	—	—	—	—	20 005 EUR	—	—	—	—	—	—	—	—	—	29 347 EUR	—	—	—	—
Non-current liabilities	10 646 EUR	—	—	—	—	—	—	23 918 EUR	—	—	—	—	—	—	—	—	—	24 516 EUR	—	—	—	—
Profit (loss)	—	—	228,000 EUR	—	228,000 EUR	—	—	—	53 797 EUR	—	—	—	—	53 797 EUR	73 300 EUR	—	73 300 EUR	—	—	—	—	—
Comprehensive income	—	— EUR	194,000 EUR	235,000 EUR	228,000 EUR	— EUR	187,000 EUR	—	53 797 EUR	— EUR	68,000 EUR	528,000 EUR	— EUR	54 257 EUR	72 919 EUR	19,000 EUR	73 300 EUR	—	— EUR	400,000 EUR	— EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	422,000 EUR	235,000 EUR	EUR	—	187,000 EUR	—	—	—	68,000 EUR	528,000 EUR	—	460,000 EUR	381,000 EUR	19,000 EUR	—	—	—	400,000 EUR	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	38 789 EUR	—	—	—	—	—	—	33 699 EUR	—	—	—	—	—	—	—	—	—	44 446 EUR	—	—	—	73 173 EUR
Tax expense (income)	—	—	521,000 EUR	—	—	—	—	—	—	—	—	—	—	2,000 EUR	3,000 EUR	—	—	—	—	—	—	—